Hindson Benjamin J.'s Form 4 filing
10x Genomics, Inc. (TXG) · filed Jul 21, 2023
- Accession no.
- 0001610717-23-000214
- Filed
- Jul 21, 2023
- Trade date
- Jul 19, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $836.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hindson Benjamin J.CIK 0001786391 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | Class A Common Stock | MOption exerciseAcquired | +12,972 | $5.04 | +$65,378.88 | 297,208 | Direct | |
| Jul 19, 2023 | Class A Common Stock | MOption exerciseAcquired | +968 | $11.48 | +$11,112.64 | 298,176 | Direct | |
| Jul 19, 2023 | Class A Common Stock | SSaleDisposed | −13,940 | $60.03F2 | −$836,818.2 | 284,236 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | Class A Common Stock | MOption exerciseDisposed | −12,972 | $0.00 | $0 | 0 | Direct | |
| Jul 19, 2023 | Class A Common Stock | MOption exerciseDisposed | −968 | $0.00 | $0 | 30,282 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $60.00 to $60.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
Remarks
President and Chief Scientific Officer